Abstract. Triggered neutrophils rapidly de-graded labeled matrices secreted by cultured, venous endothelial cells via a process dependent on elastase but not oxygen metabolites. In the presence of high concentrations of alpha-I-proteinase inhibitor, the ability of the stimulated neutrophil to solubilize the matrix was impaired. However, at lower concentrations of alpha-1-proteinase inhibitor the neutrophil could enhance the degradative potential of its released elastase by a H202-dependent process. Coincident with this increase in matrix damage, the stimulated neutrophil destroyed the elastase inhibitory activity of the alpha-1 -proteinase inhibitor via a catalase-inhibitable process. The ability of the triggered neutrophil to solubilize the matrix in the presence of alpha-l-proteinase inhibitor was unaffected by superoxide dismutase or hydroxyl radical scavengers but was markedly impaired by catalase, azide, or hypochlorous acid scavengers. We conclude that neutrophils can cooperatively use an oxidant with characteristics similar, if not identical, to hypochlorous acid and the lysosomal proteinase elastase to negate the protective effects of alphal-proteinase inhibitor in order to attack the subendothelial matnx.
Introduction
Neutrophils migrating into an inflammatory site have the potential to mediate tissue injury by either generating cytotoxic oxygen metabolites or releasing lysosomal proteinases (1, 2) . Defense mechanisms designed to control the steady state conReceivedforpublication 7 November 1983 and in revisedform 9 January 1984.
centration of released oxygen metabolites are primarily confined to intracellular sites, while proteinase activities are regulated by a complex system of extracellular antiproteinases (1, 2) . Thus, antiproteinases localized at an inflammatory site are exposed to a relatively uncontrolled oxidizing environment into which the target proteinases are released.
Recent studies have demonstrated that alpha-l-proteinase inhibitor (a-I-PI),' the primary regulator of neutrophil elastase, can be inactivated by a variety of oxidants (for examples and references see [3] [4] [5] [6] [7] [8] . Indeed, exposure of a-I-PI to phagocytegenerated oxidants effectively destroys its ability to bind or inhibit the activity of exogenous pancreatic or neutrophil elastase (3) (4) (5) (6) . This has led to the proposal that triggered neutrophils may have the ability to mediate elastase-dependent damage in the presence of a-1-PI by altering the proteinase-antiproteinase balance (3) (4) (5) (6) (7) . Although this is an attractive hypothesis, no studies have successfully demonstrated that intact phagocytes can suppress the elastase inhibitory capacity of a-I -PI at a rate that allows their coincidentally released elastase to degrade biologically relevant substrates. In this report we have examined the ability of triggered human neutrophils to degrade naked, radiolabeled matrices secreted by cultured endothelial cells in the absence or presence of a-1-PI. Our results indicate that neutrophils can use oxygen metabolites to potentiate the ability of their released elastase to solubilize a subendothelial basement membrane in the presence of a-I-PI.
Methods
Neutrophil preparation. Neutrophils were isolated from the peripheral venous blood of volunteers by Ficoll-Hypaque density centrifugation and dextran sedimentation as previously described (9) . Cells were sus-pended in Dulbecco's phosphate-buffered saline (pH 7.4) supplemented with 1 mg/ml glucose (Gibco Laboratories, Grand Island, NY).
Radiolabeled subendothelial matrices. Human umbilical vein endothelial cells were cultured in 24-well, gelatin-coated tissue culture plates (Costar 3424, 16-mm well diam, Data Packaging, Cambridge, MA) according to the methods of Maciag et al. (10) , except that 20% human serum was substituted for fetal calf serum. After the monolayers were confluent, the media was changed to proline-free M199 (Gibco Laboratories) to which [3H]proline (1.5 uCi/ml; New England Nuclear, Boston, MA) was added along with daily additions of ascorbic acid (20 Ag/ml). The cells were cultured for an additional 7-10 d with media changes every 3 d. Endothelial cell monolayers were lysed with 25 mM NH40H (30 min at 40C); and the adherent matrix was washed five times with phosphate-buffered saline and used immediately ( 11) . Total radioactivity incorporated into each matrix was determined after overnight digestion with 2 N NaOH as described in reference 1. In 45 plates (24 wells each), the total counts per minute incorporated into each individual matrix ranged from 18.5 to 42.6 X 103 (31.4±7.3 X 103 cpm/ matrix; mean± 1 SD). Within individual plates, the total counts per minute per matrix varied by <10% while plate-to-plate variation from a single pool of endothelial cells also varied by <10%. Because large differences in the total counts per minute incorporated into each matrix existed between plates obtained from different endothelial cell preparations, duplicates were always arranged within a single plate or on plates from a single endothelial cell preparation.
Matrix degradation. Matrices were incubated alone or with neutrophils in the presence or absence of phorbol myristate acetate (PMA; Consolidated Midland Corp., Brewster, NY) prepared as previously described (9) . Duplicate mixtures (1 ml final volume) were incubated at 370C in an air incubator. At selected times, the plates were centrifuged (50 g for 5 min); and 0. l-ml aliquots were removed for scintillation counting. At the end of the experiment each reaction mixture was removed, the residual matrix digested, and the total counts per minute per matrix determined for each test sample. Results are expressed as the percent radioactivity released and duplicates varied by <10%. Other additions to the matrix system included superoxide dismutase (SOD; 3,400 U/mg; Boehringer Mannheim Biochemicals, Indianapolis, IN), catalase (100,000 U/mg; Worthington Biochemical Corp., Freehold, NJ), human albumin (fatty acid free), azide, taurine, L-methionine, mannitol (Sigma Chemical Co., St. Louis, MO) and ethanol. Methoxysuccinyl-alanine-alanine-proline-valine-chloromethyl ketone (AAPVCK) and benzyloxycarbonyl-glycine-leucine-phenyl-alaninechloromethyl ketone (GLPCK) were Electrophoresis was performed at 25 mA/slab until the sample entered the resolving gel, then the current was increased to 50 mA/slab. After fixation in 50% trichloroacetic acid, treatment with EN3HANCE (New England Nuclear), and drying, gels were visualized by fluorography. High molecular weight, '4C-labeled standards were obtained from New England Nuclear.
Enzyme assays. Lactate dehydrogenase (LDH) was assayed according to Buetler (13) . The elastase inhibitory capacity of a-l-PI was assayed with porcine pancreatic elastase (Worthington Biochemical Corp.) and N-succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide (Sigma Chemical Co.) as described (14) .
All results are expressed as the mean± 1 SD.
Results
Matrix degradation by neutrophils. Neutrophils incubated alone (1.25 X 105 cells/well) or in the presence of PMA (30 ng/ml) solubilized significant amounts of the matrix ( Fig. 1 ) while control matrices incubated with buffer or PMA alone released only small amounts ofradioactivity. After a 60-min incubation, PMAstimulated neutrophils degraded -4.5 times more matrix than neutrophils alone. LDH release by PMA-stimulated cells increased by <5% during this incubation period. 65% of the radioactivity released by triggered neutrophils at 60 min was precipitable with 10% trichloroacetic acid. If the radioactive material(s) released from the matrix by triggered neutrophils was examined by SDS-PAGE and fluorography, at least seven bands could be clearly identified (Fig. 2) . The polypeptides ranged in Mr from 157,000 to 69,000, while the remainder of the radioactivity was localized at the tracking dye front (M, < 55,000).
Role ofoxygen metabolites in solubilization ofmatrix components. To determine if oxygen metabolites play a role in matrix degradation by triggered neutrophils, experiments were performed in the presence of agents designed to (a) lower the concentration of°2 (superoxide dismutase) or H202 (catalase), (b) inhibit myeloperoxidase (azide), (c) scavenge the hydroxyl radical Fig. 3 . High concentrations of a-1-PI (250 jsg/ml) inhibited matrix degradation by -90%, while lower doses that were clearly in excess of those required to inhibit the activity in cell-free supernates were much less effective. For example, 6 .25 uig ofa-1-PI inhibited matrix degradation by 1.25 X I05 triggered neutrophils by only 25% (Fig. 3) , while 0.25 ,ug of a-l-PI completely inhibited the activity in the corresponding cell-free supernates (see above). Albumin (6.25-250 ,g/ml) had no inhibitory effect on matrix solubilization by stimulated neutrophils (data not shown). At the lowest dose tested (6.25 ug/ml), ac-l-PI completely inhibited matrix degradation by the resting neutrophils (n = 10).
The requirement for higher concentrations of a-1 -PI to inhibit matrix degradation by PMA-stimulated cells suggested that a-1-PI in the fluid phase may have inadequate access to the neutrophil-matrix interface or that neutrophils were actively protecting their elastase from inactivation by a-i-PI. Because neutrophils are able to inactivate the elastase inhibitory capacity of a-1-PI by H202-dependent processes (3-6), we examined the ability of exogenous catalase to enhance the ability of a-1-PI to inhibit matrix degradation. In the presence of catalase (2.5 ug/ml), the inhibitory capacity of a-1-PI was dramatically increased (Fig. 3) . Low concentrations of a-1-PI that was coincubated with catalase inhibited matrix degradation by stimulated neutrophils comparably to the highest doses of a-1-PI tested. For example, 12.5 jig/ml of a-I-PI inhibited neutrophilmediated damage by 37.8±9.1%, while the addition of catalase increased inhibition 2.3-fold to 85.5±2.0% (n = 1). (Identical results were obtained with the highly purified a-1-PI [n = 2].)
To determine if the changes in the effectiveness of a-1-PI in the absence and presence of catalase correlated with its ability to inhibit pancreatic elastase activity, we directly examined the elastase inhibitory capacity in supernates recovered from test mixtures. Interestingly, when 12.5 jig/ml of a-1-PI were incubated with triggered neutrophils (1.25 X 105) on matrices for 60 min, there was a complete loss of the elastase inhibitory capacity (n = 5) despite the ability of this dose of a-I-PI to partially protect the matrix. (Identical results were obtained with the highly purified a-I-PI [n = 2].) Indeed, even if the a-I-PI concentration was raised to 25 jg/ml (a dose that inhibited matrix degradation by 57±16%), we could not detect any residual elastase inhibitory capacity after a 60-min incubation with 1.25 X 105 neutrophils under identical conditions. In either case, the addition of catalase (2.5 sg/ml) to the mixtures resulted in the recovery of >98% of the expected a-i-PI activity. These data indicate that triggered neutrophils (a) use an H202-dependent process to potentiate the matrix-degrading effects of released elastase in the presence of a-1-PI and (b) can destroy the elastase inhibitory capacity of large amounts of a-1-PI but not at rates that completely dissipate the protective effect of the antiproteinase.
Role ofH202 in the enhancement ofelastase-mediated damage. Our data suggest that H202 plays a pivotal role in protecting elastase from inhibition by a-1-PI. Thus, we next determined whether this effect was mediated by H202 alone or via the use of H202 as a precursor for the generation of a more reactive species (1, 15) . As demonstrated above, a-l-PI alone (12.5 jag/ ml) partially inhibited matrix degradation but its ability to protect the matrix from the triggered neutrophil was enhanced by catalase but not by heat-inactivated catalase (Table TI) . SOD slightly enhanced the ability of a-1-PI to inhibit matrix destruction but this effect was no greater than that observed with human serum albumin. Although H202 may be involved in hydroxyl radical generation (1), neither ethanol nor mannitol impaired matrix degradation in the presence ofa-I -PI. Neutrophils can use H202 in the myeloperoxidase system to generate a chlorinating species with characteristics similar if not identical to hypochlorous acid (HOCl) (9, 16, 17) . Thus, we examined the ability of the myeloperoxidase inhibitor azide and the HOCI scavengers taurine and methionine to impair the ability of the triggered neutrophil to degrade the matrix in the presence of a-1-PI. As shown in Table TI , all three agents enhanced the effectiveness of a-I-PI and decreased the ability of the neutrophil to attack the matrix to a level comparable to that observed with catalase. 
Discussion
In this study we have examined the ability oftriggered neutrophils to solubilize subendothelial matrices in the absence and presence of a-I -PI. In an antiproteinase-free environment, triggered neutrophils solubilized the matrix by a process that was primarily dependent on elastase. Although we have not identified the specific matrix components attacked by the neutrophil, the subendothelial matrix contains a number ofelastase-sensitive targets including glycoproteins (e.g., fibronectin, laminin [ 18, 19] ), proteoglycans (20) , and collagens (types I, III, and IV [20] [21] [22] [23] ). We found no evidence to suggest a direct or synergistic role for oxygen metabolites in matrix degradation but cannot exclude oxidative alterations of matrix components that do not yield soluble fragments. For neutrophils to mediate elastase-dependent damage in vivo they must contend with high concentrations of a-1-PI in the circulation and tissue spaces. It has been proposed that phagocytes could use oxygen metabolites to inactivate a-1-PI and thus protect their released elastase (3-7). However, this supposition is based on the demonstrated ability of phagocytes to inactivate a-1-PI in noncompetitive systems wherein the antiproteinase is exposed to oxidants and then exogenous elastase is added (3-7). Campbell et al. (24) have correctly argued that for this process to operate in situ, the phagocyte must oxidatively inactivate a-1-PI before the antiproteinase complexes with and inhibits elastase. In our model the fina! outcome of the competitive interplay between elastase, a-1-PI, and oxygen metabolites can be readily monitored. The potential ability of the neutrophil to shield its released elastase was first suggested by the striking differences in the a-l-PI concentration required to inhibit comparable matrix degradation by the intact cell and its corresponding supernatant. Matrix degradation by the supernates obtained from stimulated cells could be completely inhibited by as little as 0.25 ,ug of a-1-PI, while a 1,000-fold increase in the antiproteinase concentration (i.e., 250 ,ug) failed to completely block solubilization by the intact, triggered neutrophil. As the a-1-PI concentration was lowered in the intact cell system to doses ranging from 50 to 6.25 ,ug/ml (200 to 40 times higher than the dose needed to inhibit the cell-free supernatants) the protective effect of the antiproteinase rapidly decreased. Although a requirement for higher concentrations of a-i-PT in the intact cell system could solely reflect the inaccessibility of the fluid phase a--l-PI to the neutrophil-matrix interface, interventions designed to lower the concentration of oxygen metabolites dramatically enhanced the ability of a-1-PI to protect the matrix. Inhibitor studies suggest that neutrophils triggered in the presence of a--l-PT used an oxidant with characteristics similar if not identical to HOCl to potentiate the ability ofthe released elastase to attack the matrix in the presence of a-i-PI. Presently, our studies do not allow us to conclude whether the effect is mediated directly by HOCl or indirectly via the generation of endogenous N-chloroamines (15) . Nonetheless, it appears that both elastase and oxidants are released into an environment accessible to a large portion of the fluid phase a-1-PI. The final outcome of this complex interaction will be dictated by both the timing of elastase release and HOCI generation and the competing rates of oxidative inactivation of ac-l-PI, elastase inhibition by active a-I-PI, and elastase binding to sensitive target proteins. Because a-1-PI inhibits neutrophil elastase at extremely rapid rates (K.,,iatjon = 6.5 X 10' [25] ) and oxidants cannot reactivate bound elastase (5), it seems likely that the elastase is protected from a-1-PI either before or during its release. Oxidative protection of released elastase is not the only process used by the neutrophil to attack subendothelial matrix components in the presence of a-1-PI. Triggered neutrophils were able to solubilize the matrix in the presence of large amounts of a-1 -PI even while the concentration of oxygen metabolites was reduced. Indeed, we have found that neutrophils isolated from a patient with chronic granulomatous disease could also slowly degrade the matrix in the presence of a-1-PI (S. J. Weiss, unpublished observation). Whether this process represents the inability of a-1-PI to gain access to the microenvironment between the neutrophil and matrix or represents solubilization of the matrix by a-l-PI-insensitive proteinases remains to be determined. A similar oxygen-independent process of matrix degradation has been suggested in a recent report by Campbell et al. (24) . In their study, triggered neutrophils degraded '25I-fibronectin in the presence of a-1-PI by an apparent elastase-dependent process. However, in contrast to our findings, oxidative inactivation of a-1-PI did not play an important role in potentiating elastase-mediated proteolysis. Direct comparisons of the two model systems will be required to fairly assess these differences.
Quantitative analysis of the residual elastase inhibitory capacity from mixtures of stimulated cells and a-1-PI revealed that the neutrophil could completely inactivate doses of a-1-PI that provided partial protection of the subendothelial matrix. However, measurements ofthe elastase inhibitory capacity were performed with porcine pancreatic elastase, which is incapable ofbinding to oxidized a-1-PI (25) . This contrasts with the ability of oxidized a-1-PI to bind neutrophil elastase at a slower but still significant rate (6, 25) . In addition, elastase inhibitory capacity measurements determine the overall activity of a homogeneous mixture of a-1-PI and not the local concentrations of native vs. oxidized a-I -PI surrounding the triggered neutrophil and its released elastase. Our results are consistent with either a partial inhibition of matrix degradation by high concentrations of oxidized a-I -PI or the inability ofthe neutrophil to inactivate a-1-PI at rates that completely prevent partial elastase inhibition. Finally, despite the obvious limitations of elastase inhibitory capacity measurements, these results reinforce the striking ability of triggered neutrophils to lower the effective antiproteinase concentration (5). On the basis ofour taurine trapping technique, 1.25 X 105 PMA-triggered neutrophils can generate -12.5 nmol of HOCl (9) . Assuming that two to four methionyl residues may be oxidized on each a-l-PI molecule (7, 8 ), 1.25 X 105 neutrophils have the potential to inactivate 162.5-325 ,ug of the antiproteinase. (Alpha-l-PI will also be inactivated after complex formation with elastase but, 1.25 X 105 PMA-triggered neutrophils released only enough elastase to bind 0.25 ,ug of a-1-PI. In this case, the neutrophil could inactivate far larger amounts ofa-1-PI via oxidative attack than by releasing elastase.) Although high concentrations of a-l-PI may be able to prevent tissue damage by successfully complexing small amounts of released elastase in the face of an oxidative attack, the concentration of native a-1-PI will nonetheless fall. If a second wave of phagocytes then enters the inflammatory site, the oxidized a-1-PI would leave the tissue vulnerable to elastase-mediated damage.
In summary, we have demonstrated that neutrophils can negate the protective effects of a-I-PI in order to attack a subendothelial matrix via the generation of an oxidant with characteristics similar to HOCI and the release of elastase. Our results clearly indicate that triggered neutrophils can use both oxygen metabolites and proteinases in a cooperative fashion to mediate tissue damage. In these studies a nonphysiologic triggering agent, PMA, was used but physiologic stimuli likely to be encountered in vivo would be expected to mediate qualitatively similar effects. Triggering agents that might be generated in pathological states in vivo include soluble or fixed antigen-antibody complexes, opsonized particles or surfaces, high concentrations of chemotactic factors and activated complement components (1). Although these stimuli differ quantitatively in their ability to trigger an oxidative burst and lysosomal enzyme release, several studies have indicated that "weak" stimuli can elicit much greater responses depending on the physical presentation of both the triggering agent and the phagocyte (26) (27) (28) . Despite the limitations of our in vitro model, it is especially interesting to note that the findings presented here bear close analogy to reports of inactive or oxidized a-1-PI and free elastase in pulmonary lavage fluids from both cigarette smokers (29) and patients with respiratory distress syndrome (30) (31) (32) and in rheumatoid synovial fluids (33) . If HOCI and elastase are responsible for these in vivo findings, it seems likely that oxidized a-l-PI and free elastase activity will be found in a variety of neutrophil-dependent, pathological states. The model system used in this study should provide us with a powerful tool to further analyze the processes used by triggered phagocytes to mediate tissue damage and to design potential therapeutic interventions.
